Provexis plc (AIM: PXS)
0.623
-0.027 (-4.11%)
Sep 6, 2024, 3:23 PM GMT+1
Provexis Company Description
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide.
Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke.
The company’s syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats.
It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function.
The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Provexis plc
Country | United Kingdom |
Founded | 1999 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2 |
CEO | Ian Ford |
Contact Details
Address: I Ford Reading, RG1 1AZ United Kingdom | |
Phone | 44 7490 391888 |
Website | provexis.com |
Stock Details
Ticker Symbol | PXS |
Exchange | London Stock Exchange AIM |
Fiscal Year | April - March |
Reporting Currency | GBP |
ISIN Number | GB00B0923P27 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Ian Ford | Chief Executive Officer |
Ian Ford | Chief Financial Officer |